The latest closing stock price for Allogene Therapeutics as of February 21, 2025 is 2.17.
An investor who bought $1,000 worth of Allogene Therapeutics stock at the IPO in 2018 would have $-913 today, roughly -1 times their original investment - a -33.46% compound annual growth rate over 6 years.
The all-time high Allogene Therapeutics stock closing price was 54.04 on May 22, 2020.
The Allogene Therapeutics 52-week high stock price is 5.78, which is 166.4% above the current share price.
The Allogene Therapeutics 52-week low stock price is 1.32, which is 39.2% below the current share price.
The average Allogene Therapeutics stock price for the last 52 weeks is 2.79.
An investor who bought $1,000 worth of Allogene Therapeutics stock at the IPO in 2018 would have $-913 today, roughly -1 times their original investment - a -33.46% compound annual growth rate over 6 years.
The all-time high Allogene Therapeutics stock closing price was 54.04 on May 22, 2020.
The Allogene Therapeutics 52-week high stock price is 5.78, which is 166.4% above the current share price.
The Allogene Therapeutics 52-week low stock price is 1.32, which is 39.2% below the current share price.
The average Allogene Therapeutics stock price for the last 52 weeks is 2.79.